Global Biotechnology Market by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others), by Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others), and by Region (North America, Europe, Asia Pacific, Latin America, MEA), - Global Forecasts 2017 to 2027

The Global Biotechnology Market Was Valued at USD 0.7 Trillion In 2020, And It Is Expected To Reach USD 2.1 Trillion By 2027, With A CAGR Of 15.9%, During The Forecast Period (2021-2027). 

Biotechnology is the process of exploitation of biological processes in order to develop products like hormones and antibiotics often by manipulating microorganisms and genetics for industrial and other purposes. It is the type of technology that utilized a biological system or organism or parts there to develop new biological products such as enzymes, biofuels, and other desired products. Biotechnology utilizes a variety of biological processes to achieve the desired results. It includes many independent disciplines such as molecular biology, biochemistry, and genetics. In the current scenario, there is a great deal of scope in the field of biotechnology research, where the development of genetic engineering is increasing as it expands rapidly due to new possibilities that can alter the genetic material (DNA) of living organisms.

Biotechnology Market

Factors such as supportive government initiatives in developing countries, the growing demand for pharmaceuticals and individualized medicine for rare diseases, and the urgent need to innovate existing biotech technologies used in the agricultural industry are driving the biotechnology industry.

Advances in technology, product approvals and launches, and collaborations and partnerships by market players for the development and marketing of products are some of the key drivers of the market. However, the high cost of pharmaceuticals is expected to restrain the growth of the market to some extent. For instance,

The Global Biotechnology Industry Segmentation:

By Technology

  • Nanobiotechnology
  • Tissue Engineering and Regeneration
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • PCR Technology
  • Chromatography
  • Others

By Application

  • Health
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Bioinformatics
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The unique insight provided by this report also includes the following:

  1. In-depth value chain analysis
  2. Opportunity mapping
  3. Sector snapshot
  4. Key Players Positioning Matrix
  5. Regulatory scenario
  6. Strategies Adopted-Benchmarking Heat Map
  7. Market trends
  8. Covid-19 impact analysis
  9. Product comparison
  10. Pre & Post COVID 19 impact on Biotechnology Market
  11. Competitive Landscape

Based on technology, the DNA sequencing technology segment is expanding at a the highest rate during the period 2021-2027.

The DNA sequencing segment held the largest market share in 2020. The segmental growth can be attributed to the growing adoption of advanced DNA sequencing. The adoption of advance technologies will aid in improving the DNA sequencing efficiency and capacity. The nanotechnology is expected to grow at a faster growth rate during the forecast period of 2021 to 2027.

Based on the applications, the health application segment accounted for a largest market share in the overall biotechnology industry.

The Health application segment was accounted the largest share of the market in 2020. The growth is owing to the growing prevalence of diseases and investment by market players. The bioinformatics application segment is expected to observe the strong growth during the forecast period due to development and rapid adoption of informatics tools.

Based on regions, the market for biotechnology in North America accounted for the largest share in 2020.

The biotechnology market based on region is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Amongst all, North American region is anticipated to hold the largest market share in the forecast period of 2021 to 2027. Local presence of major market players, high R&D investment, and rapid adoption of these advance and costly technology in the region due to high domestic income are some of the major factors responsible for the dominance of the region. Moreover, Asia Pacific region is growing at the fastest CAGR thought the forecast period due to increasing awareness about biotechnology, growing investment by market players, and improving healthcare infrastructure.

Company Profiles and Competitive Intelligence:

The major players operating in the global biotechnology market are, AstraZeneca, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., CELGENE CORPORATION, Biogen, Abbott, Novo Nordisk A/S, Amgen Inc., Merck & Co., Novartis AG, Gilead Sciences, Inc., Sanofi Aventis, Pfizer, Inc., Lonza, and Mitra Biotech, among others.

The report also provides in-depth analysis of biotechnology market dynamics such as drivers, restraints opportunities and challenges


  1. Favourable Government Initiatives for Growth of Biotechnology Industry In Developing Nations
  2. Growing Demand for Orphan Drugs and Personalised Medicines
  3. Need to innovate the Existing Biotechnology Techniques for Agricultural Industry
  4. High Research and Development Expenditure by Biotechnology Companies
  5. Increase in Number of Biotechnology Firms
  6. Advancement in Technology


  1. High Price of Biopharmaceuticals
  2. Lack of Trained Professionals


  1. Ongoing Stem Cell Research and Expanding it’s Application
  2. Environmental Applications

COVID-19 Impact on the Biotechnology Market Analysis

COVID-19 has greatly affected the market of the Biotechnology industry. Biotechnology companies are the prime candidate for the community of drugs targeting COVID-19. For example, Gilead Sciences, Inc. acquired the U.S. FDA permission for antiviral Remdesivir for the treatment of COVID-19 patients merely after 8 months of the first case of COVID-19. Additionally, the growing engagement of the biotech industry with multinational pharmaceutical companies, drug manufacturers, diagnostic companies, and research laboratories for the production of remedial molecules to end COVID-19 is contributing to the growth of the biotechnological market.

The report also provides in-depth analysis of key trends in Biotechnology market

Sr. No.




Several biotech players invested for the development of biotechnological products for the field of food and agriculture



Outbreak of Covid 19 accelerates the research and development activities 



The report also provides in-depth analysis of recent news developments and investments

  1. In March 2021, Gilead Sciences, Inc. successfully completes its acquisition over MYR GmbH with the transaction of approximately €1.45 billion in cash consideration. The Gilead Sciences, Inc. announced the acquisition beneficiary as it provides it with Hepcludex (bulevirtide), that was conditionally approved by the EMA to treat chronic hepatitis delta virus (HDV) in adults with compensated liver disease.
  2. In March 2021, Amgen announced the acquisition over Five Prime Therapeutics, both of which are a clinical-stage biotechnology company focused on developing targeted cancer therapies, and immuno-oncology for USD 38.00 per share. This acquisition aids Amgen's leading oncology portfolio with Five Prime's innovative pipeline.
  3. In March 2019, Biogen announced its plan to acquire a company named Nightstar Therapeutics which focuses on adeno-associated virus based gene-therapies for inherited retinal disorders. This transaction was valued at USD 25.50 per share, which would count for USD 800 million in total.

Company Profiles and Competitive Intelligence

The key players operating in the market are:

  1. AstraZeneca
  2. Gilead Sciences, Inc.  
  4. Biogen
  5. Abbott
  6. Amgen Inc.
  7. Novo Nordisk A/S
  8. Merck & Co.
  9. Johnson & Johnson Services, Inc.
  10. Novartis AG
  11. Sanofi Aventis
  12. F. Hoffmann-La Roche Ltd.
  13. Pfizer, Inc.
  14. Lonza
  15. Mitra Biotech

Frequently Asked Questions (FAQs)

A few key players include, but not limited to: AstraZeneca, Gilead Sciences, Inc., CELGENE CORPORATION, Biogen, Abbott, Amgen Inc., Novo Nordisk A/S, Merck & Co., Johnson & Johnson Services, Inc., Novartis AG, Sanofi Aventis, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Lonza, and Mitra Biotech.

Biotechnology market is estimated to grow at a compound annual growth rate (CAGR) of 15.9% during 2020-2027.

Global Biotechnology market was valued at US$ 0.7 Trillion in 2020 and is anticipated to reach US$ 2.1 Trillion by 2027

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

    1. Product Outline
    2. What is Biotechnology
    3. Different types of Biotechnology  
    4. Analysis of Biotechnology  Ecosystem
    5. Supply Chain Analysis
    6. Covid -19 Impact
    7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    8. Technology Overview
  2. Regulatory Landscape for Biotechnology    
    1. Regulations and Standards
  3. Biotechnology  Market by Technology
    1. Nanobiotechnology
    2. Tissue Engineering and Regeneration
    3. DNA Sequencing
    4. Cell-based Assays
    5. Fermentation
    6. PCR Technology
    7. Chromatography
    8. Others
  4. Biotechnology  Market  by Application
    1. Health
    2. Food & Agriculture
    3. Natural Resources & Environment
    4. Industrial Processing
    5. Bioinformatics
    6. Others
  5. Regional Analysis
    1. North America
      1. US
      2. Canada
      3. Mexico
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Norway
      5. Italy
      6. Spain
      7. Netherlands
      8. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. New Zealand
      6. Rest Of Asia Pacific
    4. Middle East and Africa
    5. South America
  6. Key Strategic Insights
    1. New Raw Material Sources
    2. New Applications
    3. Emerging Technologies
    4. Opportunity mapping
    5. Critical Success Factors
    6. Environmental Impact and sustainability issues
    7. Consumer preferences
  7. Key Market Trends / Recent Developments
  8. Competitive Scenario
    1. Competitive Strategies of Key Players
      1. Mergers and Acquisitions
      2. Investments
      3. Joint Ventures
      4. New Product launches
    2. Ranking of Key Players
    3. Presence of players by Geographies
    1. AstraZeneca
    2. Gilead Sciences, Inc.  
    4. Biogen
    5. Abbott
    6. Amgen Inc.
    7. Novo Nordisk A/S
    8. Merck & Co.
    9. Johnson & Johnson Services, Inc.
    10. Novartis AG
    11. Sanofi Aventis
    12. F. Hoffmann-La Roche Ltd.
    13. Pfizer, Inc.
    14. Lonza
    15. Mitra Biotech

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization